Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lothe

Showing results (261-270 of 286) with videos related to

Pageof 29
Sort By:
Plos One|November 25, 2010
DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onsetMarianne Berg, Stine A Danielsen, Terje Ahlquist, et al.
Ebiomedicine|October 14, 2023
Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targetsMaren Høland, Kaja C G Berg, Ina A Eilertsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient groupHelge R Brekke, Franclim R Ribeiro, Matthias Kolberg, et al.
Genome Medicine|May 26, 2017
Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1Anita Sveen, Bjarne Johannessen, Torstein Tengs, et al.
Cancer Research|January 17, 2012
Oncogenicity of the developmental transcription factor Sox9Ander Matheu, Manuel Collado, Clare Wise, et al.
Hepatology (Baltimore, Md.)|February 4, 2015
Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinomaKim Andresen, Kirsten Muri Boberg, Hege Marie Vedeld, et al.
Acta Oncologica (Stockholm, Sweden)|May 10, 2021
Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancerKathinka S Slørdahl, Dagmar Klotz, Jan-Åge Olsen, et al.
Genes and Immunity|July 1, 2011
CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancerT H Ågesen, M Berg, T Clancy, et al.
Cell Reports. Medicine|May 28, 2026
Patient-derived organoids from metastatic colorectal cancer mirror tumor heterogeneity and predict patient survival and drug sensitivityKushtrim Kryeziu, Solveig K Klokkerud, Max Z Totland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 3, 2018
Prognostic markers for colorectal cancer: estimating ploidy and stromaH E Danielsen, T S Hveem, E Domingo, et al.
Pageof 29

Showing results (261-270 of 286) with videos related to

Sort By:
Pageof 29
Plos One|November 25, 2010
DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onsetMarianne Berg, Stine A Danielsen, Terje Ahlquist, et al.
Ebiomedicine|October 14, 2023
Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targetsMaren Høland, Kaja C G Berg, Ina A Eilertsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient groupHelge R Brekke, Franclim R Ribeiro, Matthias Kolberg, et al.
Genome Medicine|May 26, 2017
Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1Anita Sveen, Bjarne Johannessen, Torstein Tengs, et al.
Cancer Research|January 17, 2012
Oncogenicity of the developmental transcription factor Sox9Ander Matheu, Manuel Collado, Clare Wise, et al.
Hepatology (Baltimore, Md.)|February 4, 2015
Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinomaKim Andresen, Kirsten Muri Boberg, Hege Marie Vedeld, et al.
Acta Oncologica (Stockholm, Sweden)|May 10, 2021
Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancerKathinka S Slørdahl, Dagmar Klotz, Jan-Åge Olsen, et al.
Genes and Immunity|July 1, 2011
CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancerT H Ågesen, M Berg, T Clancy, et al.
Cell Reports. Medicine|May 28, 2026
Patient-derived organoids from metastatic colorectal cancer mirror tumor heterogeneity and predict patient survival and drug sensitivityKushtrim Kryeziu, Solveig K Klokkerud, Max Z Totland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 3, 2018
Prognostic markers for colorectal cancer: estimating ploidy and stromaH E Danielsen, T S Hveem, E Domingo, et al.
Pageof 29